Trials / Completed
CompletedNCT04214301
An Open-Label Preference Evaluation of BLI800
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate patient experience ratings of BLI800 in adult patients undergoing colonoscopy.
Detailed description
The objective of this study is to evaluate the patient satisfaction and preference of BLI800 in adult patients undergoing colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI800 | BLI800 Bowel Preparation |
Timeline
- Start date
- 2019-09-24
- Primary completion
- 2019-11-21
- Completion
- 2019-11-21
- First posted
- 2020-01-02
- Last updated
- 2023-10-23
- Results posted
- 2023-10-23
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04214301. Inclusion in this directory is not an endorsement.